[
  {
    "ts": "2026-02-25T13:08:55+00:00",
    "headline": "Charles River Laboratories to Sell Certain European Assets, Businesses; Full-Year 2026 Guidance Updated",
    "summary": "Charles River Laboratories International (CRL) said Wednesday that it has agreed to sell five Europe",
    "url": "https://finance.yahoo.com/news/charles-river-laboratories-sell-certain-130855059.html",
    "source": "MT Newswires",
    "provider": "yfinance",
    "raw": {
      "id": "4953c10a-5fef-3062-99d0-22fd555d26f9",
      "content": {
        "id": "4953c10a-5fef-3062-99d0-22fd555d26f9",
        "contentType": "STORY",
        "title": "Charles River Laboratories to Sell Certain European Assets, Businesses; Full-Year 2026 Guidance Updated",
        "description": "",
        "summary": "Charles River Laboratories International (CRL) said Wednesday that it has agreed to sell five Europe",
        "pubDate": "2026-02-25T13:08:55Z",
        "displayTime": "2026-02-25T13:08:55Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": null,
        "provider": {
          "displayName": "MT Newswires",
          "url": "https://www.mtnewswires.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-sell-certain-130855059.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/charles-river-laboratories-sell-certain-130855059.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": true,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-25T12:00:00+00:00",
    "headline": "IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities",
    "summary": "RESEARCH TRIANGLE PARK, N.C., February 25, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.",
    "url": "https://finance.yahoo.com/news/iqvia-signs-agreement-acquire-drug-120000324.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "e645b350-f3b3-349a-89dd-211665e7bb5d",
      "content": {
        "id": "e645b350-f3b3-349a-89dd-211665e7bb5d",
        "contentType": "STORY",
        "title": "IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities",
        "description": "",
        "summary": "RESEARCH TRIANGLE PARK, N.C., February 25, 2026--IQVIA Holdings Inc. (\"IQVIA\") (NYSE: IQV), a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry, today announced it has entered into an agreement to acquire certain discovery services assets from Charles River Laboratories.",
        "pubDate": "2026-02-25T12:00:00Z",
        "displayTime": "2026-02-25T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/67c3320ffc50c8b24b33de27d2fc7a98",
          "originalWidth": 546,
          "originalHeight": 209,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/nuBnL_GVQo.iqqsDsgd0dg--~B/aD0yMDk7dz01NDY7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/67c3320ffc50c8b24b33de27d2fc7a98.cf.webp",
              "width": 546,
              "height": 209,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AUaISGwD.1AMPorwuhBUPg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/67c3320ffc50c8b24b33de27d2fc7a98.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-signs-agreement-acquire-drug-120000324.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/iqvia-signs-agreement-acquire-drug-120000324.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CRL"
            },
            {
              "symbol": "IQV"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]